A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisAdvances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalRole of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideRed cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel diseaseRenal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylateEuropean evidence-based Consensus on the management of ulcerative colitis: Current management.Microscopic activity in ulcerative colitis: what does it mean?Tests of renal function in patients with quiescent colitis: effects of drug treatment.Ulcerative colitis: current treatment strategies and future prospects.Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time.Sulphasalazine in asymptomatic Crohn's disease. A multicentre trialComparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis.Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel diseaseOlsalazine in active ulcerative colitis.Incidence of sulphasalazine-induced male infertility.Inhibition of leucocyte motility by drugs used in ulcerative colitisOptimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Azo reduction of sulphasalazine in healthy volunteersAn oral preparation to release drugs in the human colon.Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapseControlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitisLongterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy.Sulphasalazine desensitisation.Management of arthropathy in inflammatory bowel diseases.Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.Some aspects of medical management of gastrointestinal disease. Part IIState of the art: IBD therapy and clinical trials in IBD.The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazineA double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.Liver and gastrointestinal function in pregnancy.Enteropathic spondyloarthritis: from diagnosis to treatment.Duration of treatment with 5-aminosalicylic acid compounds.Medical treatment of ulcerative colitisRheumatic manifestations of inflammatory bowel disease.New salicylate therapies for ulcerative colitis.
P2860
Q24246085-5D5C7E7C-C694-4DAC-8713-7D69DC4E63FAQ26798299-138871CA-B651-4B2B-828A-15EC88CF1E7BQ26801119-382BFD8E-6BDA-48DD-A7E5-B5AF2524917FQ27658886-F852B59D-7B99-46FA-840A-C7E397ADA26DQ28323157-48273F25-E38D-49CB-B78E-1D86D32CB4A5Q30581062-23A6E20C-7819-4128-BECD-D01CDA8967F9Q33562841-F02B6A24-0F27-4E47-8FEA-B82FB2895FFFQ33618202-6875A7F6-49B1-485B-A47A-C6867D6266CDQ34025054-548083D4-4E38-475A-8404-2C90AC656D2DQ34393414-01BA5621-11EF-40EA-907E-F41E75B24DA8Q34396529-5BB6C370-63CF-4359-BE64-044E09C288E3Q34408967-90C57E51-0ACC-4648-9E12-0C9CCE630B39Q34416779-470503A8-726A-470E-961A-3E472B27FB3CQ34472315-40838FBE-6E78-4C86-8F4B-E7D356FAA529Q34475193-445A1CAC-A065-461F-92C9-A9A53799D56BQ34477152-19D3B9AA-F84C-4369-8A83-1DF1E390CA03Q34492974-47C6E52A-779E-41F8-9089-F74BF25CC2EFQ34493772-27BD95B2-3BAD-4D67-90AA-ED6B825D1681Q34496132-CF076E16-9AE4-4CF3-8094-D7F440FF9B52Q34496962-332E4622-5B59-4FB9-9BCB-19D870C59DE0Q34511854-7D62B22E-5C33-4AEF-B160-C985A74D3096Q34511869-878F1A4B-9D06-418D-A84D-4BCACBB417F8Q34530099-2A7AD26E-5404-4701-9164-4E68FD1E1EADQ34530392-7B933428-E33F-4D8F-B910-A0BBEBD53F25Q34530593-C1EF1DAE-D6CE-47C3-9CD4-BD93E067BA43Q34531409-DAB0E7D8-2255-47BB-B698-19E1C5F836BDQ34531735-E13E708E-A794-490B-86BE-B8BCFB679612Q34776274-759DFBB6-808A-4D02-99A8-0075D417D646Q35091366-5EEA8C58-487B-4FB9-86D4-78FC4603429CQ35707325-9B706DA5-2B95-480B-A6D7-2D6643C05E10Q35958387-240FB878-5164-4908-878F-621D0F755386Q36299319-BE3C6EE8-4FD7-4A61-8ECF-17C50AB44019Q36706817-41423772-E55D-4A68-8895-04BFD78FFBFCQ36714570-D63F1B1B-2B33-4F00-81F6-D2C8F5DE0E69Q36715481-3AE941D5-E575-4E68-A78F-46E68FB07334Q36830824-5E857A47-F0FC-4A85-8432-A50A51F94046Q36914360-571E38D0-BFB4-410E-B392-48F19F594F2BQ37427481-1717E029-FC63-4E25-9F44-5EAFFED8D33AQ37445601-FFE5578D-5258-45E3-8AD3-75DC7F9729F2Q37598528-59500E44-89C3-4250-A78E-4AA8E3DF9040
P2860
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).
description
1973 nî lūn-bûn
@nan
1973 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
A controlled therapeutic trial ...... h sulphazalazine (Salazopyrin)
@nl
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@ast
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@en
type
label
A controlled therapeutic trial ...... h sulphazalazine (Salazopyrin)
@nl
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@ast
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@en
prefLabel
A controlled therapeutic trial ...... h sulphazalazine (Salazopyrin)
@nl
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@ast
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@en
P2860
P356
P1433
P1476
A controlled therapeutic trial ...... sulphazalazine (Salazopyrin).
@en
P2093
Dissanayake AS
Truelove SC
P2860
P304
P356
10.1136/GUT.14.12.923
P407
P577
1973-12-01T00:00:00Z